{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:55:29Z","timestamp":1791068129043,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,9,14]],"date-time":"2011-09-14T00:00:00Z","timestamp":1315958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/npp.2011.200","type":"journal-article","created":{"date-parts":[[2011,9,14]],"date-time":"2011-09-14T16:06:52Z","timestamp":1316016412000},"page":"1083-1091","source":"Crossref","is-referenced-by-count":64,"title":["Novel Cocaine Vaccine Linked to a Disrupted Adenovirus Gene Transfer Vector Blocks Cocaine Psychostimulant and Reinforcing Effects"],"prefix":"10.1038","volume":"37","author":[{"given":"Sunmee","family":"Wee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishnu P","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira Y","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Kaminsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim D","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,14]]},"reference":[{"key":"BFnpp2011200_CR1","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","volume":"24","author":"B Anton","year":"2006","unstructured":"Anton B, Leff P (2006). A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents. Vaccine 24: 3232\u20133240.","journal-title":"Vaccine"},{"key":"BFnpp2011200_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4161\/hv.5.4.7556","volume":"5","author":"B Anton","year":"2009","unstructured":"Anton B, Salazar A, Flores A, Matus M, Marin R, Hernandez JA et al. (2009). Vaccines against morphine\/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors. Hum Vaccin 5: 214\u2013229.","journal-title":"Hum Vaccin"},{"key":"BFnpp2011200_CR3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/252708a0","volume":"252","author":"KF Bonese","year":"1974","unstructured":"Bonese KF, Wainer BH, Fitch FW, Rothberg RM, Schuster CR (1974). Changes in heroin self-administration by a rhesus monkey after morphine immunization. Nature 252: 708\u2013710.","journal-title":"Nature"},{"key":"BFnpp2011200_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3565(25)22355-2","volume":"270","author":"SB Caine","year":"1994","unstructured":"Caine SB, Koob GF (1994). Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270: 209\u2013218.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2011200_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/378727a0","volume":"378","author":"MR Carrera","year":"1995","unstructured":"Carrera MR, Ashley JA, Parsons LH, Wirsching P, Koob GF, Janda KD (1995). Suppression of psychoactive effects of cocaine by active immunization. Nature 378: 727\u2013730.","journal-title":"Nature"},{"key":"BFnpp2011200_CR6","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1073\/pnas.98.4.1988","volume":"98","author":"MR Carrera","year":"2001","unstructured":"Carrera MR, Ashley JA, Wirsching P, Koob GF, Janda KD (2001). A second-generation vaccine protects against the psychoactive effects of cocaine. Proc Natl Acad Sci USA 98: 1988\u20131992.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011200_CR7","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1073\/pnas.97.11.6202","volume":"97","author":"MR Carrera","year":"2000","unstructured":"Carrera MR, Ashley JA, Zhou B, Wirsching P, Koob GF, Janda KD (2000). Cocaine vaccines: antibody protection against relapse in a rat model. Proc Natl Acad Sci USA 97: 6202\u20136206.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011200_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/3-540-26980-0_12","volume":"166","author":"T Cerny","year":"2005","unstructured":"Cerny T (2005). Anti-nicotine vaccination: where are we? Recent Results Cancer Res 166: 167\u2013175.","journal-title":"Recent Results Cancer Res"},{"key":"BFnpp2011200_CR9","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.vaccine.2009.02.105","volume":"27","author":"MJ Duryee","year":"2009","unstructured":"Duryee MJ, Bevins RA, Reichel CM, Murray JE, Dong Y, Thiele GM et al. (2009). Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines. Vaccine 27: 2981\u20132988.","journal-title":"Vaccine"},{"key":"BFnpp2011200_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/sj.npp.1301062","volume":"32","author":"S Edwards","year":"2007","unstructured":"Edwards S, Whisler KN, Fuller DC, Orsulak PJ, Self DW (2007). Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration. Neuropsychopharmacology 32: 354\u2013366.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2011200_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-006-0529-6","volume":"189","author":"DH Epstein","year":"2006","unstructured":"Epstein DH, Preston KL, Stewart J, Shaham Y (2006). Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berlin) 189: 1\u201316.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BFnpp2011200_CR12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nm1096-1129","volume":"2","author":"BS Fox","year":"1996","unstructured":"Fox BS, Kantak KM, Edwards MA, Black KM, Bollinger BK, Botka AJ et al. (1996). Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med 2: 1129\u20131132.","journal-title":"Nat Med"},{"key":"BFnpp2011200_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4161\/hv.5.4.7456","volume":"5","author":"WB Gentry","year":"2009","unstructured":"Gentry WB, Ruedi-Bettschen D, Owens SM (2009). Development of active and passive human vaccines to treat methamphetamine addiction. Hum Vaccin 5: 206\u2013213.","journal-title":"Hum Vaccin"},{"key":"BFnpp2011200_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.biopsych.2009.08.031","volume":"67","author":"M Haney","year":"2010","unstructured":"Haney M, Gunderson EW, Jiang H, Collins ED, Foltin RW (2010). Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans. Biol Psychiatry 67: 59\u201365.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2011200_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1586\/14760584.3.1.11","volume":"3","author":"M Haney","year":"2004","unstructured":"Haney M, Kosten TR (2004). Therapeutic vaccines for substance dependence. Expert Rev Vaccines 3: 11\u201318.","journal-title":"Expert Rev Vaccines"},{"key":"BFnpp2011200_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00213-007-0848-2","volume":"194","author":"AC Harris","year":"2007","unstructured":"Harris AC, Pentel PR, Lesage MG (2007). Prevalence, magnitude, and correlates of an extinction burst in drug-seeking behavior in rats trained to self-administer nicotine during unlimited access (23 h\/day) sessions. Psychopharmacology (Berlin) 194: 395\u2013402.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BFnpp2011200_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/mt.2010.280","volume":"19","author":"MJ Hicks","year":"2011","unstructured":"Hicks MJ, De BP, Rosenberg JB, Davidson JT, Moreno AY, Janda KD et al. (2011). Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs. Mol Ther 19: 612\u2013619.","journal-title":"Mol Ther"},{"key":"BFnpp2011200_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s002130000555","volume":"153","author":"KM Kantak","year":"2001","unstructured":"Kantak KM, Collins SL, Bond J, Fox BS et al. (2001). Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010. Psychopharmacology (Berlin) 153: 334\u2013340.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BFnpp2011200_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s002130050049","volume":"148","author":"KM Kantak","year":"2000","unstructured":"Kantak KM, Collins SL, Lipman EG, Bond J, Giovanoni K, Fox BS (2000). Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Psychopharmacology (Berlin) 148: 251\u2013262.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BFnpp2011200_CR20","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.intimp.2008.07.001","volume":"8","author":"DE Keyler","year":"2008","unstructured":"Keyler DE, Roiko SA, Earley CA, Murtaugh MP, Pentel PR (2008). Enhanced immunogenicity of a bivalent nicotine vaccine. Int Immunopharmacol 8: 1589\u20131594.","journal-title":"Int Immunopharmacol"},{"key":"BFnpp2011200_CR21","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S0264-410X(01)00425-X","volume":"20","author":"TR Kosten","year":"2002","unstructured":"Kosten TR, Rosen M, Bond J, Settles M, Roberts JS, Shields J et al. (2002). Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine 20: 1196\u20131204.","journal-title":"Vaccine"},{"key":"BFnpp2011200_CR22","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","volume":"66","author":"BA Martell","year":"2009","unstructured":"Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T et al. (2009). Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch Gen Psychiatry 66: 1116\u20131123.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2011200_CR23","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0022-3565(25)39413-9","volume":"266","author":"MB McClurkan","year":"1993","unstructured":"McClurkan MB, Valentine JL, Arnold L, Owens SM (1993). Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats. J Pharmacol Exp Ther 266: 1439\u20131445.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2011200_CR24","doi-asserted-by":"publisher","first-page":"10176","DOI":"10.1073\/pnas.95.17.10176","volume":"95","author":"B Mets","year":"1998","unstructured":"Mets B, Winger G, Cabrera C, Seo S, Jamdar S, Yang G et al. (1998). A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. Proc Natl Acad Sci USA 95: 10176\u201310181.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011200_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1021\/mp900213u","volume":"7","author":"AY Moreno","year":"2010","unstructured":"Moreno AY, Azar MR, Warren NA, Dickerson TJ, Koob GF, Janda KD (2010). A critical evaluation of a nicotine vaccine within a self-administration behavioral model. Mol Pharmacol 7: 431\u2013441.","journal-title":"Mol Pharmacol"},{"key":"BFnpp2011200_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4161\/hv.5.4.7457","volume":"5","author":"FM Orson","year":"2009","unstructured":"Orson FM, Kinsey BM, Singh RA, Wu Y, Kosten TR (2009). Vaccines for cocaine abuse. Hum Vaccin 5: 194\u2013199.","journal-title":"Hum Vaccin"},{"key":"BFnpp2011200_CR27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0090-9556(25)08275-3","volume":"14","author":"SM Owens","year":"1986","unstructured":"Owens SM, Mayersohn M (1986). Phencyclidine-specific Fab fragments alter phencyclidine disposition in dogs. Drug Metab Dispos 14: 52\u201358.","journal-title":"Drug Metab Dispos"},{"key":"BFnpp2011200_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","volume":"66","author":"NR Richardson","year":"1996","unstructured":"Richardson NR, Roberts DC (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1\u201311.","journal-title":"J Neurosci Methods"},{"key":"BFnpp2011200_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0092-8674(92)90213-V","volume":"68","author":"MA Rosenfeld","year":"1992","unstructured":"Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W et al. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143\u2013155.","journal-title":"Cell"},{"key":"BFnpp2011200_CR30","first-page":"125","volume":"25","author":"J Stewart","year":"2000","unstructured":"Stewart J (2000). Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 25: 125\u2013136.","journal-title":"J Psychiatry Neurosci"},{"key":"BFnpp2011200_CR31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0022-3565(25)38842-7","volume":"269","author":"JL Valentine","year":"1994","unstructured":"Valentine JL, Arnold LW, Owens SM (1994). Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats. J Pharmacol Exp Ther 269: 1079\u20131085.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2011200_CR32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0022-3565(25)20655-3","volume":"278","author":"JL Valentine","year":"1996","unstructured":"Valentine JL, Owens SM (1996). Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats. J Pharmacol Exp Ther 278: 717\u2013724.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2011200_CR33","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1124\/jpet.106.113340","volume":"320","author":"S Wee","year":"2007","unstructured":"Wee S, Specio SE, Koob GF (2007). Effects of dose and session duration on cocaine self-administration in rats. J Pharmacol Exp Ther 320: 1134\u20131143.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2011200_CR34","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1073\/pnas.0611094104","volume":"104","author":"Y Xu","year":"2007","unstructured":"Xu Y, Hixon MS, Yamamoto N, McAllister LA, Wentworth AD, Wentworth P Jr et al. (2007). Antibody-catalyzed anaerobic destruction of methamphetamine. Proc Natl Acad Sci USA 104: 3681\u20133686.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2011200_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pharmthera.2009.06.014","volume":"124","author":"N Yahyavi-Firouz-Abadi","year":"2009","unstructured":"Yahyavi-Firouz-Abadi N, See RE (2009). Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol Ther 124: 235\u2013247.","journal-title":"Pharmacol Ther"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2011200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2011200","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2011200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T23:00:10Z","timestamp":1741647610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2011200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,14]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFnpp2011200"],"URL":"https:\/\/doi.org\/10.1038\/npp.2011.200","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,14]]}}}